Connection

Marcy Bolster to Anti-Citrullinated Protein Antibodies

Back to Details
This is a "connection" page, showing publications Marcy Bolster has written about Anti-Citrullinated Protein Antibodies.
Marcy Bolster
Connection Strength
0.046
Anti-Citrullinated Protein Antibodies
  1. A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis. Rheumatology (Oxford). 2020 07 01; 59(7):1505-1513.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.